Time for equal access to breast reduction surgery in Australia

Elisabeth Elder
Med J Aust 2022; 216 (3): . || doi: 10.5694/mja2.51386
Published online: 21 February 2022

Women with symptomatic macromastia need relief from a condition that can seriously impair their quality of life

In this issue of the MJA, Crittenden and colleagues report their cost–utility analysis of breast reduction surgery for women with symptomatic breast hypertrophy in Australia.1 Their key finding is that breast reduction surgery is cost‐effective, the cost per quality‐adjusted life‐year (QALY) being considerably lower than the recommended willingness to pay thresholds in the Australian health care system. The authors prospectively assessed health‐related quality of life (SF‐6D utility scores) for 209 women with symptomatic breast hypertrophy before and 12 months after breast reduction surgery. The SF‐6D, a six‐dimensional single health utility score, is derived from the Short Form‐36 (SF‐36), one of the most widely used instruments for assessing health‐related quality of life (range: 0 for death to 1 for perfect health). Their scores were compared with those for 124 women with similar symptoms who had not yet had reduction surgery. The mean SF‐6D scores were similar at baseline, and improved significantly for the women who had undergone surgery (0.313; standard deviation [SD], 0.263 to 0.626; SD, 0.277) but declined slightly (0.296; SD, 0.267 to 0.270; SD, 0.257) for those who had not. The effectiveness of the procedure was measured as the mean differential QALY gain (1.519; 95% confidence interval, 1.362–1.675), obtained at an incremental cost‐effectiveness ratio (ICER) of $7808 per QALY gained.

  • Westmead Breast Cancer Institute, Sydney, NSW

Competing interests:

No relevant disclosures.

  • 1. Crittenden TA, Ratcliffe J, Watson DI, et al. Cost‐utility analysis of breast reduction surgery for women with symptomatic breast hypertrophy. Med J Aust 2022; 216: 147–152.
  • 2. Singh K, Losken A. Additional benefits of reduction mammaplasty: a systematic review of the literature. Plast Reconstr Surg 2012; 129: 562–570. PMID: 22090252
  • 3. Crittenden T, Watson DI, Ratcliffe J, et al; AFESA Research Group. Does breast reduction surgery improve health‐related quality of life? A prospective cohort study in Australian women. BMJ Open 2020; 10: e031804.
  • 4. Crittenden TA, Watson DI, Ratcliffe J, et al. Outcomes of breast reduction surgery using the BREAST‐Q: a prospective study and comparison with normative data. Plast Reconstr Surg 2019; 144: 1034–1044.
  • 5. Lewin R, Liden M, Lundgren J, et al. Prospective evaluation of health after breast reduction surgery using the Breast‐Q, Short‐Form 36, Breast‐Related Symptoms Questionnaire, and Modified Breast Evaluation Questionnaire. Ann Plast Surg 2019; 83: 143–151.
  • 6. Crittenden TA. Quality of life and other outcomes of breast reduction surgery [thesis]. Flinders University, Adelaide; Nov 2020.‐e41f‐4ca8‐bae8‐6f42d9b936f1/1 (viewed Dec 2021).
  • 7. Widmark‐Jensen E, Bernhardsson S, Eriksson M, et al. A systematic review and meta‐analysis of risks and benefits with breast reduction in the public healthcare system: priorities for further research. BMC Surg 2021; 21: 343.
  • 8. Winter R, Haug I, Lebo P, et al. Standardizing the complication rate after breast reduction using the Clavien–Dindo classification. Surgery 2017; 161: 1430–1435.
  • 9. Krucoff KB, Carlson AB, Shammas RL, et al. Breast‐related quality of life in young reduction mammaplasty patients: a long‐term follow‐up using the BREAST‐Q. Plast Reconstr Surg 2019; 144: 743–750.
  • 10. Australian Department of Health. Medicare Benefits Schedule: item 45523. MBS Online. (viewed Nov 2021).
  • 11. Australian Department of Health. Medicare Benefits Schedule: item 45644. MBS Online. (viewed Nov 2021).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.